Reuters logo
BRIEF-Imperial Innovations says PsiOxus begins vaccine trial
September 26, 2012 / 6:31 AM / 5 years ago

BRIEF-Imperial Innovations says PsiOxus begins vaccine trial

LONDON, Sept 26 (Reuters) - Imperial Innovations Group PLC : * portfolio company PsiOxus Therapeutics has launched the first clinical trial of its new anti-cancer vaccine, ColoAd1

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below